◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Knight Therapeutics Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 107.4M 88.1M 96.9M 92.3M 95.6M
Operating Revenue 107.4M 88.1M 96.9M 92.3M 95.6M
Cost Of Revenue 62.5M 53.2M 56.5M 47.2M 48.2M
Gross Profit 44.8M 34.9M 40.4M 45.0M 47.3M
Selling General And Administration 31.5M 26.1M 25.3M 25.5M 25.4M
General And Administrative Expense 15.8M 12.2M 10.7M 12.1M 12.1M
Research And Development 6.3M 4.8M 7.4M 5.2M 5.8M
Depreciation And Amortization In Income Statement 10.7M 9.5M 10.6M 11.2M 11.7M
Operating Expense 48.5M 40.4M 43.3M 41.8M 42.8M
Operating Income -3.7M -5.5M -3.0M 3.2M 4.5M
EBIT -13.2M 1.4M 10.3M 2.5M 3.0M
Interest Expense 2.4M 1.8M 2.4M 1.9M 2.3M
Interest Expense Non Operating 2.4M 1.8M 2.4M 1.9M 2.3M
Interest Income 2.0M 1.9M 2.7M 2.5M 2.6M
Interest Income Non Operating 2.0M 1.9M 2.7M 2.5M 2.6M
Net Interest Income -348,000 98,000 215,000 608,000 300,000
Other Income Expense -11.6M 5.0M 10.6M -3.2M -4.1M
Other Non Operating Income Expenses -2.2M -140,000 -1.1M 795,000 42,000
Special Income Charges 893,000 574,000 1.7M 1.1M 2.1M
Gain On Sale Of Security -10.3M 4.6M 10.1M -5.1M -6.2M
Pretax Income -15.6M -399,000 7.9M 608,000 713,000
Tax Provision -3.0M -2.6M -2.9M 523,000 2.7M
Tax Effect Of Unusual Items -1.8M 777,000 1.8M -599,700 -618,450
Net Income From Continuing And Discontinued Operation -12.6M 2.2M 10.7M 85,000 -1.9M
Net Income From Continuing Operation Net Minority Interest -12.6M 2.2M 10.7M 85,000 -1.9M
Net Income Including Noncontrolling Interests -12.6M 2.2M 10.7M 85,000 -1.9M
Net Income Common Stockholders -12.6M 2.2M 10.7M 85,000 -1.9M
Net Income -12.6M 2.2M 10.7M 85,000 -1.9M
EBITDA -1.1M 12.9M 24.3M 15.9M 16.2M
Normalized EBITDA 8.3M 7.8M 12.5M 19.9M 20.3M
Reconciled Depreciation 12.1M 11.6M 14.0M 13.4M 13.2M
Basic EPS -0.13 0.02 -- 0.00 -0.02
Diluted EPS -0.13 0.02 -- 0.00 -0.02
Basic Average Shares 99.6M 99.6M -- 101.1M 101.3M
Diluted Average Shares 99.6M 100.1M -- 101.1M 101.3M
Total Unusual Items -9.4M 5.2M 11.8M -4.0M -4.1M
Total Unusual Items Excluding Goodwill -9.4M 5.2M 11.8M -4.0M -4.1M
Tax Rate For Calcs 0.19 0.15 0.15 0.15 0.15
Normalized Income -5.0M -2.2M 743,250 3.5M 1.6M
Amortization 10.7M 9.5M 10.6M 11.2M 11.7M
Amortization Of Intangibles Income Statement 10.7M 9.5M 10.6M 11.2M 11.7M
Depreciation Amortization Depletion Income Statement 10.7M 9.5M 10.6M 11.2M 11.7M
Diluted NI Availto Com Stockholders -12.6M 2.2M 10.7M 85,000 -1.9M
Net Income Continuous Operations -12.6M 2.2M 10.7M 85,000 -1.9M
Net Non Operating Interest Income Expense -348,000 98,000 215,000 608,000 300,000
Other Gand A 15.8M 12.2M 10.7M 12.1M 12.1M
Other Special Charges -893,000 -574,000 -1.7M -1.1M -2.1M
Reconciled Cost Of Revenue 61.1M 51.1M 53.2M 45.0M 46.7M
Selling And Marketing Expense 15.7M 13.9M 14.6M 13.4M 13.3M
Total Expenses 111.0M 93.6M 99.8M 89.1M 91.1M
Total Operating Income As Reported -3.7M -5.5M -3.0M 3.2M 4.5M
Line Item Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 77.8M 112.2M 80.1M 73.8M 60.8M
Cash Cash Equivalents And Short Term Investments 116.4M 180.9M 172.8M 172.3M 157.5M
Cash Equivalents 10.2M 2.8M 5.1M 5.8M 2.2M
Cash Financial 67.7M 109.4M 75.0M 67.9M 58.6M
Other Short Term Investments 38.6M 68.7M 92.7M 98.6M 96.7M
Accounts Receivable 97.3M 116.4M 105.2M 91.2M 85.0M
Receivables 107.7M 125.5M 113.5M 103.0M 94.9M
Inventory 148.7M 140.2M 102.7M 115.0M 103.6M
Prepaid Assets 7.3M 7.5M 7.7M 7.3M 4.6M
Current Assets 380.1M 454.0M 396.8M 397.6M 360.6M
Gross PPE 20.5M 21.0M 68.3M 21.6M 21.5M
Accumulated Depreciation -- -- -48.2M -- --
Net PPE 20.5M 21.0M 20.0M 21.6M 21.5M
Goodwill 90.8M 90.0M 86.5M 84.8M 84.6M
Goodwill And Other Intangible Assets 474.9M 363.1M 370.1M 364.5M 380.2M
Other Intangible Assets 384.1M 273.0M 283.6M 279.7M 295.5M
Investments And Advances 78.0M 87.5M 103.4M 105.6M 110.9M
Total Non Current Assets 657.8M 549.0M 567.0M 564.7M 584.8M
Total Assets 1.0B 1.0B 963.8M 962.3M 945.4M
Current Debt 18.8M 20.7M 17.5M 18.7M 17.0M
Current Debt And Capital Lease Obligation 22.2M 24.2M 20.1M 21.7M 19.6M
Accounts Payable 104.9M 117.7M 78.3M 86.6M 77.8M
Payables 113.3M 125.8M 89.2M 94.3M 84.5M
Payables And Accrued Expenses 113.3M 125.8M 89.2M 94.3M 84.5M
Other Current Liabilities 18.4M 2.6M 1.9M 2.2M 1.8M
Current Liabilities 153.9M 152.6M 111.2M 118.2M 105.8M
Long Term Debt 78.8M 26.3M 25.9M 33.0M 34.0M
Long Term Debt And Capital Lease Obligation 82.5M 29.7M 29.3M 36.5M 38.6M
Long Term Capital Lease Obligation 3.7M 3.4M 3.4M 3.6M 4.6M
Total Non Current Liabilities Net Minority Interest 120.9M 55.0M 57.4M 70.2M 76.7M
Total Liabilities Net Minority Interest 274.9M 207.6M 168.7M 188.4M 182.6M
Common Stock 532.6M 531.2M 534.3M 539.3M 540.9M
Capital Stock 532.6M 531.2M 534.3M 539.3M 540.9M
Additional Paid In Capital 27.9M 26.7M 25.7M 26.2M 25.7M
Retained Earnings 144.2M 156.8M 154.8M 144.2M 144.3M
Gains Losses Not Affecting Retained Earnings 58.3M 80.6M 80.2M 64.1M 51.8M
Other Equity Adjustments 58.3M 80.6M 80.2M 64.1M 51.8M
Common Stock Equity 763.1M 795.4M 795.1M 773.9M 762.8M
Stockholders Equity 763.1M 795.4M 795.1M 773.9M 762.8M
Total Equity Gross Minority Interest 763.1M 795.4M 795.1M 773.9M 762.8M
Total Capitalization 841.9M 821.8M 821.0M 806.9M 796.8M
Net Tangible Assets 288.2M 432.4M 425.0M 409.4M 382.6M
Tangible Book Value 288.2M 432.4M 425.0M 409.4M 382.6M
Working Capital 226.2M 301.4M 285.6M 279.4M 254.8M
Invested Capital 860.7M 842.4M 838.5M 825.6M 813.8M
Total Debt 104.7M 53.9M 49.5M 58.2M 58.1M
Net Debt 19.8M -- -- -- --
Share Issued 99.7M 99.4M 100.0M 101.0M 101.3M
Ordinary Shares Number 99.7M 99.4M 100.0M 101.0M 101.3M
Accrued Interest Receivable -- -- 845,000 -- --
Available For Sale Securities 78.0M -- 103.4M 105.6M 110.9M
Buildings And Improvements -- -- 18.5M -- --
Capital Lease Obligations 7.1M 6.9M 6.1M 6.6M 7.2M
Current Capital Lease Obligation 3.4M 3.6M 2.6M 3.0M 2.6M
Financial Assets Designatedas Fair Value Through Profitor Loss Total -- 87.5M -- -- --
Finished Goods -- -- 84.9M -- --
Income Tax Payable 313,000 235,000 213,000 2.5M 918,000
Investmentin Financial Assets 78.0M 87.5M 103.4M 105.6M 110.9M
Land And Improvements -- -- 8,000 -- --
Machinery Furniture Equipment -- -- 42.6M -- --
Non Current Accounts Receivable 46.7M 45.0M 3.4M 44.4M 44.4M
Non Current Deferred Assets 29.1M 24.6M 21.2M 20.9M 20.5M
Non Current Deferred Liabilities 3.1M 3.4M 3.8M 4.3M 4.9M
Non Current Deferred Taxes Assets 29.1M 24.6M 21.2M 20.9M 20.5M
Non Current Deferred Taxes Liabilities 3.1M 3.4M 3.8M 4.3M 4.9M
Non Current Prepaid Assets 8.7M 7.9M 48.8M 7.7M 7.3M
Other Current Borrowings 18.8M 20.7M 17.5M 18.7M 17.0M
Other Equity Interest -- 117,000 117,000 117,000 117,000
Other Payable 8.1M 7.9M 10.7M 5.1M 5.7M
Other Properties 20.5M 21.0M 7.2M 21.6M 21.5M
Other Receivables 5.0M 4.2M 1.9M 7.3M 5.8M
Properties -- -- 0.00 -- --
Raw Materials -- -- 12.1M -- --
Taxes Receivable 5.4M 5.0M 5.6M 4.5M 4.1M
Total Tax Payable 313,000 235,000 213,000 2.5M 918,000
Tradeand Other Payables Non Current 35.4M 21.8M 24.3M 29.5M 33.2M
Work In Process -- -- 5.7M -- --
Line Item Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow 20.3M 3.7M 1.5M 5.0M -1.1M
Cash Flow From Continuing Operating Activities 20.3M 3.7M 1.5M 5.0M -1.1M
Depreciation And Amortization 12.1M 11.6M 14.0M 13.4M 13.2M
Depreciation Amortization Depletion 12.1M 11.6M 14.0M 13.4M 13.2M
Stock Based Compensation 2.5M 1.0M -502,000 801,000 1.1M
Deferred Tax -3.1M -3.1M 953,000 -1.3M 1.4M
Deferred Income Tax -3.1M -3.1M 953,000 -1.3M 1.4M
Change In Working Capital 13.0M -11.5M -12.2M -11.0M -11.9M
Changes In Account Receivables 15.5M -11.6M -3.9M -10.0M 2.8M
Change In Receivables 15.2M -12.5M -3.4M -9.2M 998,000
Change In Inventory 9.5M -39.2M 5.2M -9.6M -5.7M
Change In Payables And Accrued Expense -9.9M 38.8M -11.5M 11.3M -9.6M
Change In Payable -9.9M 38.8M -11.5M 11.3M -9.6M
Change In Other Current Liabilities -848,000 610,000 -323,000 -16,000 582,000
Other Non Cash Items 4.1M 1.3M 2.4M 154,000 617,000
Capital Expenditure -25.1M -3.7M -1.1M -2.0M -17.4M
Purchase Of PPE -620,000 -373,000 -560,000 -374,000 -688,000
Net PPE Purchase And Sale -620,000 -343,000 -460,000 -374,000 -685,000
Purchase Of Business -106.9M -- -- -- 0.00
Purchase Of Investment -7.1M -7.0M -36.7M -46.8M -42.7M
Sale Of Investment 24.0M 42.8M 55.7M 60.4M 71.9M
Net Investment Purchase And Sale 17.0M 35.8M 19.0M 13.6M 29.2M
Investing Cash Flow -101.3M 32.1M 18.0M 11.5M 11.8M
Cash Flow From Continuing Investing Activities -101.3M 32.1M 18.0M 11.5M 11.8M
Issuance Of Debt 109.4M 1.8M 543,000 1.6M 747,000
Repayment Of Debt -55.9M -2.7M -8.0M -3.0M -7.9M
Net Issuance Payments Of Debt 53.5M -899,000 -7.4M -1.4M -7.2M
Repurchase Of Capital Stock -6,000 -3.3M -5.2M -2.5M -1.2M
Net Common Stock Issuance -6,000 -3.3M -5.2M -2.5M -1.2M
Common Stock Payments -6,000 -3.3M -5.2M -2.5M -1.2M
Financing Cash Flow 50.8M -4.7M -15.4M -3.9M -11.4M
Cash Flow From Continuing Financing Activities 50.8M -4.7M -15.4M -3.9M -11.4M
Effect Of Exchange Rate Changes -4.1M 952,000 2.2M 332,000 -1.3M
Changes In Cash -30.2M 31.1M 4.2M 12.6M -695,000
Beginning Cash Position 112.2M 80.1M 73.8M 60.8M 62.8M
End Cash Position 77.8M 112.2M 80.1M 73.8M 60.8M
Free Cash Flow -4.9M -31,000 394,000 3.0M -18.5M
Income Tax Paid Supplemental Data 689,000 1.0M 990,000 915,000 2.0M
Interest Paid Supplemental Data 3.1M 569,000 2.9M 503,000 3.3M
Cash Dividends Paid 0.00 0.00 0.00 0.00 0.00
Change In Account Payable -10.0M 38.7M -9.5M 9.4M -8.7M
Change In Income Tax Payable 81,000 66,000 -2.0M 1.8M -887,000
Change In Prepaid Assets -933,000 817,000 -2.2M -3.4M 1.7M
Change In Tax Payable 81,000 66,000 -2.0M 1.8M -887,000
Gain Loss On Investment Securities -- 945,000 -8.3M 2.8M 665,000
Interest Paid Cff -3.1M -569,000 -2.9M -503,000 -3.3M
Long Term Debt Issuance 109.4M 1.8M 543,000 1.6M 747,000
Long Term Debt Payments -55.9M -2.7M -8.0M -3.0M -7.9M
Net Business Purchase And Sale -106.9M -- -- -- 0.00
Net Foreign Currency Exchange Gain Loss -1.5M 1.3M -5.5M 98,000 -4.1M
Net Income From Continuing Operations -12.6M 2.2M 10.7M 85,000 -1.9M
Net Intangibles Purchase And Sale -24.5M -3.3M -515,000 -1.7M -16.7M
Net Long Term Debt Issuance 53.5M -899,000 -7.4M -1.4M -7.2M
Net Other Financing Charges 225,000 -- -- -- --
Net Other Investing Changes 13.8M -- 0.00 -- --
Operating Gains Losses -1.5M 2.3M -13.8M 2.9M -4.1M
Proceeds From Stock Option Exercised 138,000 114,000 140,000 448,000 340,000
Purchase Of Intangibles -24.5M -3.3M -515,000 -1.7M -16.7M
Sale Of PPE 0.00 30,000 -- -- 3,000
Unrealized Gain Loss On Investment Securities 5.7M -- -- -- 665,000
NEWS
Loading news...
TRENDING
Loading...